Morgan Stanley lowered the firm’s price target on Brown-Forman (BF.A) (BF.B) to $27 from $29 and keeps an Underweight rating on the shares. Given structural headwinds to alcohol, American whiskey oversupply, and likely stepped-up competitive pressure, cost pressures are compounding a difficult topline outlook, the analyst contends.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BF.B:
- Brown-Forman price target lowered to $30 from $33 at Barclays
- Brown-Forman price target lowered to $30 from $32 at Evercore ISI
- Brown-Forman sees 100-150bps of gross margin compression in FY27, FY28
- Morning Movers: Moderna rises after entering COVID settlement agreement
- Brown-Forman backs FY26 organic net sales view down low-single digit range